Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The study will be a multi-center, parallel, group, placebo control, double-blind, randomized
controlled trial of lamictal as add-on maintenance treatment in pediatric outpatients (aged
10 to 17 years) diagnosed with Bipolar I disorder. The study consists of 4 phases: Screen
(approximately 2 weeks), Open label phase (up to 18 weeks), Randomized phase (up to 36 weeks)
and Taper and follow-up phase (up to 4 weeks).